FDA Approves New Once-Weekly Contraceptive Patch, Gwyn Lo

The U.S. FDA has approved Gwyn Lo™ (norelgestromin and ethinyl estradiol transdermal system), a new low-dose estrogen combined hormonal contraceptive patch. This once-weekly patch is approved for pregnancy prevention in women of childbearing potential with a BMI below 30 kg/m². The approval follows positive results from the Phase 3 Luminous Study, offering a new convenient option for contraception.